Do acute hepatopancreatic necrosis disease-causing PirABVP toxins aggravate vibriosis? by Tran, Thi Ngoc Phuong et al.
Full Terms & Conditions of access and use can be found at
https://www.tandfonline.com/action/journalInformation?journalCode=temi20
Emerging Microbes & Infections
ISSN: (Print) (Online) Journal homepage: https://www.tandfonline.com/loi/temi20
Do acute hepatopancreatic necrosis disease-
causing PirABVP toxins aggravate vibriosis?
Phuong Thi Ngoc Tran , Vikash Kumar & Peter Bossier
To cite this article: Phuong Thi Ngoc Tran , Vikash Kumar & Peter Bossier (2020) Do acute
hepatopancreatic necrosis disease-causing PirABVP toxins aggravate vibriosis?, Emerging
Microbes & Infections, 9:1, 1919-1932, DOI: 10.1080/22221751.2020.1811778
To link to this article:  https://doi.org/10.1080/22221751.2020.1811778
© 2020 The Author(s). Published by Informa
UK Limited, trading as Taylor & Francis
Group, on behalf of Shanghai Shangyixun
Cultural Communication Co., Ltd
View supplementary material 
Accepted author version posted online: 16
Aug 2020.
Published online: 02 Sep 2020.
Submit your article to this journal 
Article views: 291
View related articles 
View Crossmark data
Do acute hepatopancreatic necrosis disease-causing PirABVP toxins aggravate
vibriosis?
Phuong Thi Ngoc Trana*, Vikash Kumara,b* and Peter Bossiera
aLab of Aquaculture & Artemia Reference Center, Department of Animal Sciences and Aquatic Ecology, Faculty of Bioscience Engineering,
Ghent University Ghent, Belgium; bICAR-Central Inland Fisheries Research Institute (CIFRI), Barrackpore, India
ABSTRACT
Gram-negative marine bacterium Vibrio parahaemolyticus is an important aquatic pathogen and has been demonstrated
to be the causative agent of acute hepatopancreatic necrotic disease (AHPND) in shrimp aquaculture. The AHPND-causing
V. parahaemolyticus strains contain a pVA1 plasmid encoding the binary PirAVP and PirBVP toxins, are the primary virulence
factor that mediates AHPND andmortality in shrimp. Since PirABVP toxins are secreted extracellularly, one can hypothesize
that PirABVP toxins would aggravate vibriosis in the aquatic environment. To address this, in vivo and in vitro experiments
were conducted. Germ-free Artemia franciscana were co-challenged with PirABVP toxins and 10 Vibrio spp. The in vivo
results showed that PirABVP toxin interact synergistically with MM30 (a quorum sensing AI-2 deficient mutant) and
V. alginolyticus AQ13-91, aggravating vibriosis. However, co-challenge by PirABVP toxins and V. campbellii LMG21363,
V. parahaemolyticus CAIM170, V. proteolyticus LMG10942, and V. anguillarum NB10 worked antagonistically, increasing
the survival of Artemia larvae. The in vitro results showed that the addition of PirABVP toxins significantly modulated
the production of the virulence factors of studied Vibrio spp. Yet these in vitro results did not help to explain the in
vivo results. Hence it appears that PirABVP toxins can aggravate vibriosis. However, the dynamics of interaction is strain
dependent.
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Introduction
Shrimp is a highly traded seafood product [1–3]. Inten-
sification of shrimp production has increased the inci-
dence of disease. In the shrimp aquaculture industry,
economic losses from disease outbreak have been esti-
mated by the FAO to be over US$9 billion per year,
which is approximately 15% of the value of world
farmed shellfish production [4,5]. The bacterial disease
problem, often vibriosis, has escalated since late 2010,
when the industry collapsed in South-Asian countries
[6,7]. The Vibrio harveyi, V. alginolyticus,
V. anguillarum, V. splendidus, V. salmonicida,
V. vulnificus, and V. parahaemolyticus strains have
been found as the main vibriosis-causative microor-
ganisms [6–9].
Apart from “classical” vibriosis, some Vibrio spp.
are also responsible for causing acute hepatopancreatic
necrosis disease (AHPND), originally known as early
mortality syndrome (EMS), having a devastating
impact on the shrimp aquaculture industry [10–14].
The shrimp production in AHPND-affected regions
has at times dropped considerably (up to 60%) and
disease has caused an estimated loss of US $43 billion
across Asia (China, Malaysia, Thailand, Vietnam)
and in Mexico in last 10 years [15–19]. A Vibrio spp.
becomes a virulent AHPND-causing strain by acquir-
ing a pVA1 plasmid (63-70 kb) encoding the binary
toxin PirAVP/PirBVP, which consists of two subunits
PirAVP and PirBVP, homologous to the Photorhabdus
luminescens insect-related (Pir) toxins PirA/PirB [11].
The secreted binary PirAVP and PirBVP toxins are the
primary virulence factor of AHPND-causing bacteria
mediating AHPND and mortality in shrimp [19–22].
Notably, some recent studies have reported the pres-
ence of PirABVP carrying pVA1 plasmids in some
non-Vibrio parahaemolyticus such as V. campbellii,
V. owenseii, and V. harveyi [23–26]. That sparks the
concern about the influence of AHPND-causing Pir-
ABVP toxin on the virulence of non-AHPND Vibrio
species, when these toxic proteins are released into
the aquatic environment or in the host.
However, the critical problem in studying in vivo
host-pathogen interaction is the difficulty to either
eliminate or extricate the effect of the microbial
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communities that occur naturally in the system [27].
Additionally, in germ-associated conditions, the
microbial communities might influences the physi-
ology of host-associated microbes, thereby making it
difficult to understand the host response towards
pathogens [28,29]. Consequently, the selection of an
appropriate animal model system that permits better
delineation of cause and effects in host-pathogen inter-
actions is paramount. The brine shrimp (Artemia fran-
ciscana), an aquatic invertebrate that can be reared
under gnotobiotic conditions (allowing full control
over the host-associated microbial communities) are
characteristically small, highly osmotolerant, branchio-
pod crustacean reported from a variety of harsh
environment worldwide [27,30–33]. Apart from its
unusual life history, relatively low space and cost
requirement for culture, rapid generation cycle (cyst
to adult in 20–30 days), well-characterized develop-
mental stages and ability to form cyst which can be
stored, makes A. franciscana an exceptional exper-
imental system to study the host and pathogen
relationship [34–37]. In addition, the brine shrimp
genome sequence shares high homology with the gen-
omes of shrimps and other crustaceans. Hence, the
outcome of Artemia-based studies might provide a
basis for a better understanding of host-pathogen inter-
actions in commercially important shrimp species
[38,39].
In this study, using the highly controlled gnotobiotic
brine shrimp model system, it was aimed to investigate
whether PirABVP toxin proteins would aggravate the
virulence of 10 Vibrio spp., i.e. V. harveyi (wild type
and 4 quorum sensing deficient mutants, each of
them with a certain degree of virulence attenuation
relative to the wild type), V. proteolyticus,
V. alginolyticus, V. campbellii, V. anguillarum, and
non-AHPND V. parahaemolyticus. Additionally, in
vitro experiments were also carried out to determine
the bacterial cell viability, biofilm formation, swim-
ming motility, haemolytic activity, caseinase activity,
and lipase activity in response to PirABVP toxin. Over-
all, the results contribute to the understanding of the
potential of AHPND toxins to aggravate vibriosis.
Material and methods
Bacterial species and growth conditions
Eleven bacterial species including 10 Vibrio spp.
(V. harveyi BB120, BB152, JMH603, MM30, JMH634,
V. alginolyticus AQ13-91, V. campbellii LMG21363,
V. parahaemolyticus CAIM170, V. proteolyticus
LMG10942, and V. anguillarum NB10) and Aeromo-
nas hydrophila LVS3 bacteria were used in the study
(Table 1). It is important to mention that the strain
V. harveyi ATCC strain BAA-1116 (BB120) has been
reclassified as Vibrio campbellii based on microarray
comparative genome hybridization and multilocus
sequence analysis [40,41]. The Vibrio spp. were used
for challenge assay, while A. hydrophila LVS3 (auto-
claved) served as feed for Artemia larvae. The stock cul-
ture of bacteria was streaked onto Marine agar (MA)
plates (Carl Roth, Belgium) to obtain pure colonies.
Afterwards, a single colony was inoculated in a
50 mL Erlenmeyer flask containing 20 mL marine
broth (MB) (Carl Roth, Belgium) and incubated over-
night at 28°C under constant agitation (120 rpm). The
stock culture of each bacterial species was prepared
using 30% glycerol and stored at −80°C until further
use.
Preparation of recombinant
V. parahaemolyticus PirAVP and PirBVP
The PirA (pET21b PirAVP) and PirB plasmid (pET21b
PirBVP) obtained from Taiwan [10] were transformed
into E. coli Rosetta (DE3) competent cells and the
expression and purification of recombinant PirAVP
and PirBVP toxins were done as described by Kumar
et al. [21]. Briefly, the expression of C-terminal
His6-tagged PirAVP and PirBVP proteins was induced
by the addition of 0.25 μM of isopropyl thiogalactoside
(IPTG). After expression had proceeded at 16°C for
16 h, the recombinant proteins were purified with the
magneHis™ protein purification system (Promega
Corporation, USA). The purified recombinant PirAVP
and PirBVP toxins were dialyzed in phosphate buffer
solution (PBS) (Honeywell, Belgium) and concentrated
with Amicon® ultra-15 centrifugal filters (Merck Milli-
pore, USA). The acquired PirAVP and PirBVP toxins
were collected and immediately preserved at −80°C
for further analysis.
Detection of V. parahaemolyticus PirAVP and
PirBVP toxins through SDS-PAGE
After purification, the quality and quantity of the
recombinant PirAVP and PirBVP proteins was checked
by SDS-PAGE and Bradford method, respectively, as
described by Kumar et al. (2019). The proteins were
electrophoresed in stain-free 4-20% polyacrylamide





BB152 (Mutation in LuxM: HAI-1 synthase)
JMH603 (Mutation in CqsA: CAI-1 synthase)
MM30 (Mutation in LuxS: AI-2 synthase)
JMH634 (Mutation in LuxM, LuxS and CqsA synthase)
Vibrio alginolyticus AQ13-91 (Wild type)
Vibrio campbellii LMG21363 (Wild type)
Vibrio parahaemolyticus CAIM170 (Wild type)
Vibrio proteolyticus LMG10942 (Wild type)
Vibrio anguillarum NB10 (Wild type)
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gel, with each lane receiving an equivalent volume
(10 μL) of toxin. The gels were then stained with Coo-
massie Biosafe (BioRad Laboratories) and visualized by
a ChemiDoc MP imaging system (BioRad, Belgium)
for qualitative analysis of recombinant PirAVP and
PirBVP toxins. The concentration of protein was deter-
mined using the Bradford method [42].
Gnotobiotic brine shrimp rearing system
The gnotobiotic brine shrimp larvae were produced by
hatching brine shrimp cysts axenically (germ-free) fol-
lowing decapsulation and hatching procedures as
described by Kumar et al. [43] with slight modifi-
cations. Briefly, 30 mg Artemia franciscana cysts
(INVE Aquaculture, Dendermonde, Belgium) was
hydrated in 10 mL distilled water with 2 µm filtered
aeration for 1 h. Then, 330 µL NaOH (32%) and
5 mL NaOCl (50%) were added to decapsulate the
cysts. After 4 min, the decapsulation was stopped by
adding 5 mL autoclaved Na2S2O3 (10 g/L). The decap-
sulated cysts were washed with filtered autoclaved
artificial seawater (FASW) containing 35 g/L instant
ocean synthetic sea salt (Aquarium Systems, Sarre-
bourg, France) to get rid of the decapsulation reagents.
The cysts were then suspended in 50 mL falcon tubes
containing 30 ml FASW followed by incubating at
28°C on the rotor with constant illumination of
about 27 µE/m2/sec for 28 h to reach the developmen-
tal stage II. After hatching, the axenic condition was
checked by spreading 100 µL of hatching water on
MA plate and then incubated for 5 days at 28°C [28].
Experiments that started with non-axenic larvae were
discarded.
Brine shrimp challenge assay
To investigate whether it was possible to conduct the
challenge test in smaller volume of FASW, a total of
three separate in vivo assays were performed. At first,
the challenge assay was performed in two different con-
tainers: glass tubes (10 mL FASW) and Eppendorf
tubes (1 mL FASW). The results showed that there
was significant difference in the survival of Artemia
nauplii in the non-challenged (control) group in both
glass tubes and Eppendorf tubes. Statistically, the survi-
val rates of Artemia nauplii in the control were signifi-
cantly different from those challenged with V. harveyi
BB120 (immersion, 107 cells/ml) in two containers
after 48 h (Figure S1 A, B). Next, the survival assay
was conducted in 96-well plates with 100 µL/well
FASW to investigate the survival performance of Arte-
mia nauplii in even smaller volume (Figure S1 C). The
experiment was performed with three Artemia nauplii
density, i.e. 1 nauplius/well, 5 and 10 nauplii/well.
Average survival rate of Artemia nauplii in the control
group with a stocking density of 1 nauplius/well was
approximately 75% and 25%, in 5 nauplii/well 87%
and 35% and 89% and 47% in 10 nauplii/well group
after 48 and 60 h post experiment (Figure S1 C).
Based on the above results, the 96-well plates contain-
ing 10 Artemia nauplii in 100 µL FASW were found
suitable and used further for challenge experiments
in this study. The McFarland standard (BioMerieux,
Marcy L’Etoile, France) was used to determine the bac-
terial density from optical density (OD) assuming
1.2 × 109 cells/ml at OD of 1 [44].
Next, to determine the feeding regime for Artemia
larvae in 96-well plates during 60 h of the experiment,
additional survival assay was performed. Along with
previously reported feeding regime, i.e. 107 cells/ml
used in 10 and 1 ml FASW challenge assay [21,45],
an additional feeding 108 cells/ml was used and fed
either once or twice to the Artemia larvae. The results
indicated that the survival of Artemia larvae fed twice
was significantly higher than those fed once after
60 h in both feeding doses (Figure S2 A). However,
there was no significant difference in Artemia survival
between two feeding levels, i.e. 107 cells/ml or 108 cells/
ml. Afterwards, the Artemia larvae were challenged
with V. harveyi BB120 strain and the survival was
recorded after 48 and 60 h post infection. The results
showed that feeding doses (107 or 108 cells/ml) did
not result in any significant difference in the survival
of Artemia larvae challenged with V. harveyi BB120
strain (Figure S2 B). However, higher survival (%)
were recorded in Artemia nauplii fed twice at 108
cells/ml as compared with 107 cells/ml feeding regimes,
in the challenge assay with V. harveyi strains (Figure
S3). Therefore, the feeding dose 108 cells/ml, fed
twice, was used for further experiment.
After standardization, 96-well plates containing
100 µL FASW, 10 A. franciscana larvae per well and
feeding twice at 108 LVS3 cells/ml was applied in
further challenge assays. In the first experiment, a
group of 10 larvae was transferred to 96-well plates
and challenged separately with either V. harveyi
BB120 (wild type), BB152 (HAI-1 deficient mutant),
JMH603 (CAI-1 deficient mutant), MM30 (AI-2
deficient mutant), JMH634 (triple QS mutant),
V. alginolyticus AQ13-91, V. campbellii LMG21363,
V. parahaemolyticus CAIM170, V. proteolyticus
LMG10942 orV. anguillarumNB10 strain (immersion,
107 cells/ml) followed by incubation at 28°C for 60 h.
The non-challenge Artemia larvae served as control.
The survival rate of Artemia was recorded every 12 h
post challenge. The experiment was carried out in 12
replicates equivalent to 12 wells of the plate. Next,
the survival assay was carried out using four exper-
imental groups, i.e. only Artemia larvae, Artemia larvae
+ bacterial strain, Artemia larvae + PirABVP toxin
(immersion, 5.2 µg/100 µL) and Artemia larvae + bac-
terial strain + PirABVP toxin (immersion, 5.2 µg/
100 µL). In our previous publications, we found that
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Pir toxins at 5.2 µg/100 µl induce AHPND, damages
gastrointestinal tract, causing mortality in brine shrimp
larvae [21,46]. Hence, 5.2 µg/100 µL dose was used to
further investigate its role on the virulence of non-
AHPND Vibrio species. The plates were maintained
at 28°C for 60 h and every 12 h, the survival rate of
Artemia was recorded by placing the plates under the
microscope. The experiment was carried out in 12
replicates equivalent to 12 wells of the plate.
Cell viability investigation by flow cytometry
At first, cell viability assay was standardized using
different dye and bacterial concentration. It was
found that Thiazole Orange and Propium Iodide
were detected in FITC (fluorescein isothiocyanate)
channel and PC5.5 channel, respectively, in the Cyto-
FLEX flow cytometer system (Beckman Coulter’s Life
sciences, France). Hence, the plots of PC5.5-A as the
vertical axis and FITC-A as a horizontal axis were
used to present the results. The results showed that
Thiazole Orange was able to stain both live and dead
bacterial cells, while Propium Iodide only stained
dead cells (Table S1). Notably, the mixture of both
dyes was able to distinguish both live and dead cells
in the sample better than those only stained with
only one dye (Table S1). Therefore, the mixture of
Thiazole Orange and Propium Iodide was used for
further cell viability test in this study. Moreover,
another experiment was carried out to determine
how dead cells of tested bacterial strains locate on the
PC5.5 × FITC plot. Subsequently, the logarithm of sig-
nal emission from dead cells of the examined strains
was at least from 103 to 104 on PC5.5 axis. Particularly,
the signal areas of dead cells belonging to V. harveyi
strains (except for JMH634) and V. anguillarum
NB10 were gated from 5 × 103 above while to
V. harveyi JMH634 was at 104 above (Figure S4 A,
B). The dead cells of other strains emitted the signal
at 103 above in terms of area logarithm (Figure S4 C).
Next, the overnight bacteria cultures adjusted to 107
cells/mL were used for flow cytometry analysis. Bac-
teria suspension supplemented with 5.2 µg/100 µL Pir-
ABVP toxin protein was used as treatment while the
pure suspension served as control. Afterwards, the bac-
teria suspension was incubated at 28°C for 24 h under
constant agitation (6 rpm) followed by centrifugation
(2000× g at 25°C) for 15 min. Subsequently, the pellets
were resuspended in FASW and up to 10−3 serial
dilution was prepared. Afterwards, 100 µL of acquired
suspension was placed into each well of the 96-well
plates together with 5 µL Thiazole Orange (17 mM)
and 5 µL Propium Iodide (0.15 mM). The mixture of
100 µL of FASW and dyes was used as a negative con-
trol. The experiment was conducted in triplicate equiv-
alent to 3 wells of the plate. The plate was then covered
by the aluminium foil for 10 min to allow staining
reaction to occur. The amount of total count and
dead bacterial cells were then determined by CytoFLEX
flow cytometer system.
In vitro assay for the biofilm formation,
swimming motility, caseinase activity,
haemolytic activity, and lipase activity of Vibrio
spp.
Before performing the in vitro assay, the bacterial sus-
pension was diluted to 107 cells/mL using sterile MB
and supplemented with PirABVP toxin at 5.2 µg/
100 µL. The bacteria suspension without PirABVP
toxin served as a positive control. Subsequently, a
final volume of 500 µL from each group was trans-
ferred to Eppendorf tubes and incubated at 28°C for
24 h under constant agitation (6 rpm).
Biofilm formation was quantified as described by
Stepanovic et al. [47]. Briefly, the bacterial suspension
from two groups described above was adjusted to
OD550 of 0.1 and 200 µL aliquots was transferred, in
triplicate, into the wells of a sterile 96-well plate.
Wells receiving only MB served as a negative control.
The plate was incubated at 28°C for 24 h under static
conditions to allow the biofilm formation. Afterwards,
each well was gently washed three times with 300 µL
physiological solution (0.9% NaCl) to remove all the
non-adherent bacteria. The wells were supplemented
with 200 µL of 99% methanol and incubated for 2 h.
The methanol was removed from each well and the
plate was air-dried overnight. Subsequently, the wells
were stained with 150 µL of 0.1% crystal violet for
20 min, rinsed under a gentle flow of tap water and
allowed to air dry. Then, wells were supplemented
with 150 µL of 95% ethanol to resolubilize the bounded
dye from the adherent bacterial cells and absorbance
was measured at 570 nm with an infinite 200 Tecan
plate reader (Tecan, Switzerland).
Swimming motility was measured as described by
Yang and Defoirdt [48]. The bacterial suspension
from two groups described above was adjusted to
OD550 of 0.5 and 2 µL of the sample was spotted at
the centre of fresh soft MA (0.2% agar) plates. The
pure MB served as negative control. The plates were
incubated at 28°C for 24 h. Thereafter, the diameters
of the motility halos were measured. Each treatment
was conducted in triplicate.
Caseinase activity was measured as described by
Natrah et al. [49]. The required volume of medium
was divided into two parts, one of which consisted of
MB (80 g/L) and agar (30 g/L), and the other half
was supplemented with 8% (w/v) skim milk powder.
The former was autoclaved at 121°C for 20 min while
the latter only needed 5 min of autoclaving. After
that, the homogenous mixture of both suspensions
was poured into plastic Petri dishes and allowed to
air dry. The bacterial suspension from two groups
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described above was adjusted to OD550 of 0.5 and 2 µL
of the sample was spotted at the centre of the agar
plates. The plates were then incubated at 28°C for 3–
4 days. Afterwards, the diameters of the clearing zone
and colonies were measured. Each treatment was con-
ducted in triplicate.
Hemolytic activity and lipase activity were measured
as described by Natrah et al. [49] on 5% defibrinated
sheep blood supplemented with 1% Tween 80 on MA
plates. 2 µL of aliquots (OD550 of 0.5) were spotted at
the centre of the agar plates followed by the incubation
at 28°C for 3–4 days. Pure MB was used as negative
control. Afterwards, the diameters of activity zones
and colonies were observed. Each treatment was con-
ducted in triplicate.
Statistical analysis
Survival data were arcsine transformed to satisfy nor-
mality and homoscedasticity requirements as necessary
and then analysed by SPSS software version 24.0. The
Independent samples T-test and one-way ANOVA
(analysis of variances) followed by Duncan’s multiple
range test was used to compare means of survival
rate between unchallenged and bacterial challenged
shrimp. The interactive effect of PirABVP toxin and
tested bacteria were determined by two-way ANOVA
(which allows to subsequently determine if the effect
is additive, synergistic, or antagonistic) at 5 different
time points. Survival in all treatments had to be higher
than 10%, at a certain time point, for an interactive
effect to be considered and the interpretation of the
results to be reliable. Moreover, the data obtained
from in vitro tests were analysed by independent
samples T-test. The Significance level was set at p <
0.05.
Results
Virulence of Vibrio spp. towards A. franciscana
larvae
In the first experiment, the virulence of Vibrio isolates
to the host Artemia larvae was investigated by monitor-
ing survival at every 12 h, until 60 h post challenge
(Table 2). The results illustrated that the virulence of
wild type V. harveyi and its derivatives and other
studied Vibrio isolates were notably different from
each other 48 h post challenge. The Artemia larvae
challenged with V. proteolyticus LMG10942,
V. campbellii LMG21363, V. parahaemolyticus
CAIM170, V. harveyi BB120 (wild type) and BB152
strain (HAI-1 deficient mutant) exhibited significantly
high mortality as compared to others Vibrio isolates
and control 48 h post challenge. Although, the survival
of Artemia larvae in V. alginolyticus AQ13-91,
V. harveyi MM30 (AI-2 deficient mutant) and
JMH603 strain (CAI-1 deficient mutant) group was
significantly lower as compared to the control, the
Vibrio-induced mortality was lower than for other
Vibrio isolates after 48 h post challenge (Table 2).
Interestingly, at 60 h post challenge, a similar trend
in the survival of Artemia larvae was observed in
V. proteolyticus LMG10942, V. campbellii LMG21363,
V. anguillarum NB10, V. parahaemolyticus
CAIM170, V. harveyi BB120 (wild type) and BB152
strain (HAI-1 deficient mutant) challenged groups.
Moreover, V. harveyi JMH634 strain (triple QS
mutant) was found to be non-pathogenic and the sur-
vival of Artemia larvae was similar to the control
group. These results indicate that Vibrio isolates exhib-
ited a different degree of virulence to Artemia larvae.
As established before, the virulence of V. harveyi and
its derivatives were found to be quorum-sensing (QS)
dependent [50,51].
Effect of PirABVP toxin on virulence factor
production and in vivo virulence of V. harveyi
wild type and its isogenic quorum-sensing
mutants.
An in vitro experiment was conducted aiming to deter-
mine the effect of PirABVP toxin on cellular viability of
V. harveyi wild type BB120 and mutant strains. The
overnight culture of bacteria and PirABVP toxin mix-
ture was tested for live/dead cells using Thiazole
Orange and Propium Iodide staining using flow cyto-
metry. The result showed that addition of PirABVP tox-
ins significantly increased the total cell count and
percentage of dead cells in the suspension of MM30
strain (AI-2 deficient mutant) (Table 3, S2). In con-
trast, a significant decreased total cell count was
recorded in the suspensions of BB152, JMH603, and
JMH634 strain supplemented with the toxin. Mean-
while, no significant difference in dead/live cell pro-
portion (dead cells %) was observed in the other
V. harveyi strains tested (Table 3). The addition of Pir-
ABVP toxins had no effect on BB120 strain cellular
viability.
The supplementation of PirABVP toxin significantly
enhances the expression of virulence factors, including
swimming motility, caseinase activity, and lipase
activity of V. harveyi BB120 strain (wild type), while
the haemolytic activity of bacterium was suppressed
in the presence of PirABVP (Table 4, S3). However, in
BB152 (HAI-1 deficient mutant) and MM30 (AI-2
deficient mutant) strains, the addition of PirABVP
toxin significantly enhances the swimming motility
and caseinase activity (only in BB152 strain), while
biofilm formation, haemolytic activity, and lipase
activity was not significantly altered (Table 4, S4, S5).
In addition, PirABVP toxin supplementation increased
the biofilm formation and swimming motility of
JMH603 (CAI-1 deficient mutant), while increased
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lipase activity was observed with the JMH634 (triple
QS mutant) strain (Table 4, S6, S7). These results indi-
cate that addition of PirABVP toxin potentially
increases the virulence of the studied V. harveyi
BB120 (wild type), MM30 (AI-2 deficient mutant),
BB152 (HAI-1 deficient mutant), JMH603 (CAI-1
deficient mutant) and JMH634 (triple QS mutant)
strains, while increased total cell count was only
reported from V. harveyi MM30 strain.
Under the in vivo experiment, at first, the quality of
the purified PirAVP and PirBVP toxins was analysed
through SDS-PAGE. The purified recombinant PirAVP
and PirBVP toxins were found at approximately 13 and
50 kDA, respectively, in SDS-PAGE gels (Figure S5).
Next, the effect of PirABVP toxin on the virulence of
V. harveyi wild type and its derivatives towards Arte-
mia was investigated (Figure 1). The results illustrated
that PirABVP toxin challenge in combination with
either V. harveyi BB120 (wild type), BB152 (HAI-1
deficient mutant), or JMH603 (CAI-1 deficient
mutant) display additive effect (no interaction) at 36
and 48 h post challenge and high mortality in Artemia
larvae was recorded. At 60 h post challenge, the BB120,
BB152, or JMH603 strain displayed a statistically sig-
nificant synergistic interaction with PirABVP toxin
(Figure 1(A–C)). This synergistic effect, towards the
end of the challenge period with survival in some treat-
ments becoming very low, might be an inherent feature
of survival data with questionable biological meaning.
Moreover, significant synergistic interaction of Pir-
ABVP toxin with MM30 (AI-2 deficient mutant) at
36 h (with survival higher than 15% in all treatments)
to 60 h post challenge was observed (Figure 1(D)). In
contrast, no considerable interaction between PirABVP
toxin and JMH634 (triple QS mutant) strain was
detected (Figure 1(E)). These results suggest that Pir-
ABVP toxin can interact with some Vibrio strains
(more specifically the AI2 mutant, as such mildly viru-
lent towards Artemia), increasing its virulence towards
Artemia larvae while there is no increase in virulence
by Pir toxins, when the strain is avirulent (such as
the triple QS mutant JMH634).
Effect of PirABVP toxin on virulence factor
production and in vivo virulence of
V. alginolyticus AQ1391
Next, the effect of PirABVP toxin supplementation on
in vivo virulence of V. alginolyticus AQ1391 strain
was investigated in Artemia larvae. The results showed
that in presence of the PirABVP toxin, V. alginolyticus
AQ1391 induce significant mortality in Artemia larvae
(Figure 2(A)). In addition, a significant synergistic
interaction between PirABVP toxin and
V. alginolyticus AQ1391 was observed at 48 and 60 h
post challenge.
Table 2. Survival (%) of Artemia franciscana at different time points after being challenged with V. harveyi wild type and its quorum
sensing mutants (mean ± SD, n = 12).
Treatments 12 h 24 h 36 h 48 h 60 h
Control 99.2 ± 2.9a 99.2 ± 2.9a 99.2 ± 2.9b 90.8 ± 6.7e 62.5 ± 12.2e
V. harveyi strains
BB120 (Wild type) 95.8 ± 5.2a 95.0 ± 6.8a 85.8 ± 9.9a 43.3 ± 16.1c 7.5 ± 8.7b
BB152 (HAI-1-) 97.5 ± 6.2a 95.0 ± 6.7a 88.3 ± 10.3a 44.2 ± 10.8c 13.3 ± 12.3bc
JMH603 (CAI-1-) 99.2 ± 2.9a 99.2 ± 2.9a 96.7 ± 4.9b 57.5 ± 8.7c 7.5 ± 7.5b
MM30 (AI-2-) 98.3 ± 3.9a 98.3 ± 3.9a 97.5 ± 4.5b 75.0 ± 7.9d 21.7 ± 15.4c
JMH634 (triple QS mutant) 97.5 ± 4.5a 97.5 ± 4.5a 97.5 ± 4.5b 91.7 ± 8.4e 69.2 ± 9.0e
V. alginolyticus AQ13-91 99.2 ± 2.9a 99.2 ± 2.9a 95.8 ± 7.9b 60.0 ± 11.3b 14.2 ± 9.0bc
V. campbellii LMG21363 100a 99.2 ± 2.9a 93.3 ± 9.8ab 31.8 ± 15.9b 4.2 ± 5.2b
V. parahaemolyticus CAIM170 100a 99.2 ± 2.9a 89.2 ± 13.1a 38.3 ± 17.5b 5.8 ± 5.2b
V. proteolyticus LMG10942 99.2 ± 2.9a 99.2 ± 2.9a 92.5 ± 9.7ab 11.7 ± 15.3a 0.8 ± 2.9a
V. anguillarum NB10 99.2 ± 2.9a 99.2 ± 2.9a 97.5 ± 4.5b 80.0 ± 6.0d 44.2 ± 7.9d
Note: The non-challenged group served as control. Significant differences within the column between control and treatment bacterial groups at each
sampling point are indicated with different superscript (p < 0.05).
Table 3. Average (±SD) cell counts and dead cells percentage
of V. harveyiwild type BB120 and its derivatives with or without
PirABVP (PirAB+ or PirAB-), obtained from flow cytometer (n =
3).
Total count (×103 cells/ml) Dead cells (%)
PirAB- PirAB+ PirAB- PirAB+
BB120 (wild
type)
559.3 ± 38.5a 500.9 ± 10.3a 2.7 ± 0.4A 2.4 ± 0.3A
BB152 (HAI-1-) 792.1 ± 10.0b 734.8 ± 5.7a 1.5 ± 0.3A 1.7 ± 0.2A
JMH603 (CAI-1-) 650.8 ± 18.5b 580.8 ± 12.8a 1.5 ± 0.2A 1.9 ± 0.1A
MM30 (AI-2-) 943.2 ± 27.6a 1051.0 ± 15.7b 1.3 ± 0.1A 1.8 ± 0.2B
JMH634 (triple
QS mutant)
377.9 ± 6.0b 144.4 ± 3.7a 5.2 ± 0.2A 5.0 ± 0.1A
Note: Different superscripts indicate significant difference (p < 0.05).
Table 4. The effect of PirABVP on virulence factors of V. harveyi
wild type BB120 and its derivatives (n = 3).
Category of in
vitro tests















NSE NSE ↑* NSE ND
Swimming
motility
↑** ↑** ↑*** ↑** ND
Haemolysis
activity
↓* NSE NSE NSE ND
Caseinase
activity
↑*** ↑** ↓* ↓** ND
Lipase activity ↑*** NSE ↓* NSE ↑***
Note: ND = not detected, NSE = no significant effect (p > 0.05), ↑: increase,
↓: decrease; *(p < 0.05), **(p < 0.01), ***(p < 0.001).
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The in vitro results illustrated that PirABVP toxin
had no significant effect on the proportion of dead
cells of V. alginolyticus AQ1391 strain as compared
to the control (p = 0.082490). However, the total cell
count in the PirABVP toxin supplemented group was
notably higher than the control (Table 5, S8). The,
V. alginolyticus AQ1391 did not display biofilm for-
mation, haemolytic, caseinase and lipase activity
(Table 6, S9). Taken together, the results showed that
the addition of PirABVP toxin significantly increases
the in vivo virulence and total cell count of
V. alginolyticus AQ1391 strain. In contrast, PirABVP
toxin had no effect on dead/live cell proportion and
in vitro virulence of V. alginolyticus.
Effect of PirABVP toxin on virulence factor
production and in vivo virulence of
V. campbellii LMG21363
Interestingly, the addition of PirABVP toxin signifi-
cantly decreases the in vivo virulence of V. campbellii
LMG21363 toward Artemia larvae. The results showed
that after 48 h post PirABVP toxin and V. campbellii
LMG21363 exposure, the survival of brine shrimp
Figure 1. Survival (%) of Artemia franciscana at different time points after being challenged with PirABVP toxin @ 5.2 µg/100 µl and
Vibrio harveyi strains (A) PirABVP toxin and V. harveyi wild type BB120 strain, (B) PirABVP toxin and HAI-1 deficient mutant BB152
strain, (C) PirABVP toxin and CAI-1 deficient mutant JMH603 strain, (D) PirABVP toxin and AI-2 deficient mutant MM30 strain and
(E) PirABVP toxin and QS triple mutant JMH634 strain. The error bars represent the standard deviation values of 12 replicates. Aster-
isks on the top of error bars indicate the significant in vivo interaction, either synergistic or antagonistic interaction between toxin
and bacteria, and based on output interaction plot obtained from two-way ANOVA analysis *(p < 0.05), **(p < 0.01), ***(p < 0.001).
The effect of the toxin or the Vibrio is not statistically analysed and hence not presented here, only the interactive compound of the
2-way ANOVA is presented. For an interactive statistical effect to be considered of biological relevance, only data at timepoints for
which the survival in all treatments was above 10% are considered.
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larvae was significantly higher by approximately 5% as
compared to larvae only challenged with bacteria
(Figure 2(B)).
The cell viability of V. campbellii LMG21363 was
affected by the presence of PirABVP toxin. Results
showed that dead cells (%) in LMG21363 strain
Figure 2. Survival (%) of A. franciscana at different time points after being challenged with PirABVP toxin @ 5.2 µg/100 µl and (A)
V. alginolyticus AQ13-91, (B) V. campbellii LMG21363 (C) V. parahaemolyticus CAIM170, (D) V. proteolyticus LMG10942 and (E)
V. anguillarum NB10. The error bars represent the standard deviation values of 12 replicates. Asterisks on the top of error bars indi-
cate the significant in vivo interaction, either synergistic or antagonistic interaction between toxin and bacteria, and based on out-
put interaction plot obtained from two-way ANOVA analysis *(p < 0.05), **(p < 0.01), ***(p < 0.001). The effect of the toxin or the
Vibrio is not statistically analysed and hence not presented here, only the interactive compound of the 2-way ANOVA is presented.
For an interactive statistical effect to be considered of biological relevance, only data at timepoints for which the survival in all
treatments was above 10% are considered.
Table 5. Average (±SD) cell counts and dead cells percentage of V. alginolyticus AQ1391, V. campbellii LMG21363, V. proteolyticus
LMG10942, V. parahaemolyticus CAIM170 and V. anguillarum NB10 strains with or without PirABVP (PirAB+ or PirAB-), obtained from
flow cytometer (n = 3).
Bacterial species
Average cell count (×103 cells/ml) Dead cells (%)
PirAB- PirAB+ PirAB- PirAB+
V. alginolyticus AQ13-91 4267.0 ± 67.8 a 5942.7 ± 72.8b 2.1 ± 1.2 A 0.5 ± 0.1A
V. campbellii LMG21363 4339.1 ± 36.7a 5639.7 ± 62.4b 0.5 ± 0.0 B 0.3 ± 0.0A
V. parahaemolyticus CAIM170 3383.4 ± 143.2 b 2090.8 ± 68.8 a 2.4 ± 0.5A 3.0 ± 0.2A
V. proteolyticus LMG10942 4027.0 ± 82.7a 4894.0 ± 69.1b 7.1 ± 0.2 B 4.7 ± 0.2A
V. anguillarum NB10 1197.4 ± 22.7a 999.5 ± 46.8 a 1.4 ± 0.2A 1.1 ± 0.0A
Note: Different superscripts indicate significant difference (p < 0.05).
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supplemented with PirABVP toxin was lower than the
non-supplemented suspension (PirAB-). In addition,
the total cell count of LMG21363 strain with PirABVP
toxin was significantly higher than the control (Table
5, S8). Though, V. campbellii LMG21363 did not exhi-
bit biofilm formation and lipase activity, the presence
of PirABVP toxin significantly enhanced the haemolytic
activity of LMG21363 strain. Moreover, the addition of
PirABVP toxin had no significant effect on swimming
motility and caseinase activity of LMG21363 strain
(Table 6, S10). These results indicate that, PirABVP
toxin antagonistically interacts with V. campbellii
LMG21363 strain and significantly decreases its in
vivo virulence. In addition, the PirABVP toxin signifi-
cantly increase the in vitro total cell count and haemo-
lytic activity V. campbellii LMG21363, while no effect
was observed in swimming motility and caseinase
activity.
Effect of PirABVP toxin on virulence factor
production and in vivo virulence of
V. parahaemolyticus CAIM170
The AHPND-causing PirABVP toxin significantly
decreases the in vivo virulence of V. parahaemolyticus
CAIM170 strain (antagonistic interaction of PirABVP
toxin and CAIM170 strain). The results showed that
Artemia larvae challenged together with PirABVP
toxin and CAIM170 strain had significantly higher sur-
vival at 48 h post exposure as compared with larvae
challenged with bacteria only (Figure 2(C)).
The PirABVP toxin had no significant effect on the
cell viability of V. parahaemolyticus CAIM170 strain.
The total cell count and live/dead cells proportion
were found similar in CAIM170 strain with or without
PirABVP toxin addition (Table 5, S8). Though,
V. parahaemolyticus CAIM170 did not exhibit
biofilm formation and lipase activity, the addition of
PirABVP toxin was found to increase the swimming
motility of bacterium. However, PirABVP toxin sup-
plementation significantly decreases the haemolytic
activity of CAIM170 strain (Table 6, S11). These results
indicate that PirABVP toxin interacts antagonistically
with V. parahaemolyticus CAIM170 in vivo and
decreases its virulence. Moreover, PirABVP toxin
enhances the swimming motility of bacterium, while
decreases the haemolytic activity of CAIM170 strain.
Effect of PirABVP toxin on virulence factor
production and in vivo virulence of
V. proteolyticus LMG10942
Similar to V. campbellii LMG21363, the PirABVP toxin
supplementation had antagonistic interaction on in
vivo virulence of V. proteolyticus LMG10942 strain
towards Artemia larvae. The results showed that,
after 48 h exposure with PirABVP toxin and
LMG10942 strain, the survival of Artemia larvae sig-
nificantly increased as compared with larvae chal-
lenged with bacteria alone (Figure 2(D)).
Next, the effect of PirABVP toxin on cell viability of
V. proteolyticus LMG10942 was investigated. The data
obtained from flow cytometry analysis illustrated that
the addition of PirABVP toxin significantly increased
the total cell count of LMG10942 strain (Table 5, S8).
Moreover, the dead cells (%) in LMG10942 were
lower in the presence of toxin as compared to control.
Among the studied virulence factors, V. proteolyticus
LMG10942 did not exhibit haemolytic, caseinase, and
lipase activies, while the addition of PirABVP toxin
did not affect the swimming motility of
V. proteolyticus LMG10942 (Table 6, S12). Together,
these results show that PirABVP toxin interacts antag-
onistically with V. proteolyticus LMG10942 in vivo
and decreases its virulence. Moreover, PirABVP toxin
had no effect on the in vitro virulence of
V. proteolyticus LMG10942.
Effect of PirABVP toxin on virulence factor
production and in vivo virulence of
V. anguillarum NB10
The results showed that the addition of PirABVP
toxin had no effect on the virulence of
V. anguillarum NB10 strain in Artemia larvae up to
48 h post challenge. The Artemia larvae challenged
with V. anguillarum NB10 with or without PirABVP
toxin was approximately 68 ± 11% and 68 ± 8%,
respectively, after 48 h exposure. However, at 60 h
post challenge, the supplementation of PirABVP
toxin significantly decreases the virulence of NB10
strain and the average survival (%) of Artemia chal-
lenged with the mixture of bacteria and toxin was
higher than those challenged with only bacteria
(Figure 2(E)) (antagonistic interaction).
Table 6. The effect of PirABVP on virulence factors of the studied Vibrio spp (n = 3).
Category of in vitro tests











Biofilm formation ND ND ND ND ND
Swimming motility NSE NSE ↑* Overgrew ↓*
Haemolysis activity ND ↑* ↓* ND NSE
Caseinase activity ND NSE NSE ND NSE
Lipase activity ND ND ND ND ND
Note: ND = not detected, NSE = no significant effect (p > 0.05), ↑: increase, ↓: decrease; *(p < 0.05), **(p < 0.01), ***(p < 0.001).
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The addition of PirABVP toxin had no effect on the
cell viability of V. anguillarum NB10 strain. The results
showed that NB10 strain supplemented with PirABVP
toxin did not cause significant change in the percentage
of the dead cells as compared to the control. Notably,
the average total cells count without toxin supplemen-
tation was significantly higher than those with toxin
(Table 5, S8). Moreover, the addition of PirABVP
toxin on V. anguillarum NB10 had no effect on studied
biofilm formation, lipase activity, haemolytic activity
and caseinase activity. In contrast, the presence of Pir-
ABVP significantly reduced the swimming motility of
V. anguillarum NB10 (Table 6, S13). Though, PirABVP
toxin interacts antagonistically with V. anguillarum
NB10 strain and decrease its virulence (in vivo), the
toxin had no significant effect on the in vitro pro-
duction of virulence factors (except swimming moti-
lity) of the NB10 strain.
Discussion
The Gram-negative Vibrio species, ubiquitous in estu-
arine and coastal waters, are opportunistic aquatic
pathogen and responsible for causing AHPND and
vibriosis in shrimps [8,20]. For instance, V. harveyi,
V. alginolyticus, V. anguillarum, V. splendidus,
V. salmonicida, V. vulnificus, and
V. parahaemolyticus causing conventional vibriosis in
shrimp farming [6–9]. While, pVA1 plasmid associated
V. parahaemolyticus, V. punensis, V. harveyi,
V. owensii, and V. campbelli are reported to cause
AHPND and massive mortality, even up to 100%, in
shrimp aquaculture [10–12,21,25,26,52,53]. As
AHPND-causing bacteria are releasing extracellular
PirABVP toxins, their presence in the aquatic environ-
ment, apart from mediating AHPND and mortality in
shrimp (@20 µg toxin/g shrimp) [21,54–56], may
modulate the intra and inter-species interaction and
influence virulence of non-AHPND Vibrio species.
To this end, brine shrimp (Artemia franciscana), an
aquatic invertebrate crustacean and a model for crus-
tacean shrimp [28,29,36,39,57] was used to investigate
in vivo effect of PirABVP toxin on the virulence of non-
AHPND vibrios during challenge studies. Sub-
sequently, in vitro experiments were also carried out
to determine the bacterial cell viability, biofilm for-
mation, swimming motility, and the haemolytic, case-
inase, and lipase activities in the non-AHPND vibrios
in response to PirABVP toxin exposure.
Quorum sensing (QS) is a bacterial intercommuni-
cation system that controls the expression of numerous
genes, thereby regulating the activities of large group of
cells [58–60]. QS system use small signal molecules
called autoinducers (AIs) that controls the bacterial
bioluminescence, virulence factor expression, biofilm
formation, motility, entry into stationary phase, sporu-
lation, and mating [61,62]. In vibrios, three parallel QS
system have been discovered: AI-1, a typical acylated
homoserine lactones (AHLs), CAI-1 (V. cholerae auto-
inducer 1), and the AI-2, have been designed for inter-
species cell-cell communication [63,64]. Hence, we
hypothesized that quorum sensing might regulate the
PirABVP toxin-induced Vibrio species virulence and
subsequent vibriosis in shrimp. To verify this,
V. harveyi BB120 (wild type), BB152 (HAI-1 deficient
mutant), JMH603 (CAI-1 deficient mutant), MM30
(AI-2 deficient mutant) and JMH634 (triple QS
mutant) strains were used, each of them with a certain
degree of virulence attenuation relative to the wild type.
The results showed that addition of PirABVP toxin
synergistically enhanced in vivo virulence of
V. harveyiMM30 only, while no significant interaction
was observed in triple QS mutant JMH634 strain
(Figure 1(A–D), Figure 2(A)). Moreover, additive
effect was noticed in BB120 and BB152 strains. These
observations point in the direction of additive effects
for strains that are virulent (wild type or strains in
which quorum sensing gene deletions do not affect
virulence), synergistic effects for strains with an attenu-
ated (intermediate) virulence (MM30) and no affect for
avirulent strains like the triple QS mutant. It is possible
that the PirABVP toxins, known to destroy epithelial
cells in the Artemia gut [21,22,46,65–69], facilitate
the entry of MM30 strain, making epithelial cells a
barrier to infection for MM30 cells. Additionally, the
PirABVP toxin supplementation also synergistically
increases the in vivo virulence of V. alginolyticus
AQ13-91 strain (wild type), an intermediate virulent
strain. In both cases more research will be needed to
unravel the mechanistic nature of the observed syner-
gistic effect.
However, supplementation of PirABVP toxin has
significant antagonistic interaction with in vivo viru-
lence of V. campbellii LMG21363,
V. parahaemolyticus CAIM170, V. proteolyticus
LMG10942, and V. anguillarum NB10 strain (Figure
2(B–E)). The results showed that, after exposure with
PirABVP toxin and Vibrio spp., the survival of Artemia
larvae significantly increased as compared with larvae
challenged with bacteria alone. The cellular and
humoral components of the immune system present
in the digestive tract plays an important role in pre-
venting the potential binding and invasion of incoming
pathogen [70]. There are few reports which suggest
that the administration of bacterial toxins could serve
as cross-protective antigens and provide protection
against microbial infection. For instance, Campa-Cor-
dona et al. [71] reported that recombinant PirA-like
toxin, when administered through bath immersion,
enhances the immune response of shrimp, providing
protection against AHPND-causing
V. parahaemolyticus [71]. In another study, ToxAVP
toxin, when administrated to Pacific red snapper Lutja-
nus peru was reported to positively affect the humoral
1928 P. T. Tran et al.
immune response and upregulate the expression of
immune genes that protects the red snapper from
V. parahaemolyticus infection [72,73]. As, PirABVP
toxin were reported to bind epithelial cells of the diges-
tive tract in brine shrimp larvae, the toxin binding
might have induced immunological response and pre-
vented the subsequent attachment and/or entry of
pathogenic bacteria. Alternatively, as reported in sea
bass larvae (Dicentrarchus labrax), the gut epithelial
enterocytes containing lysosomes mediates intracellu-
lar elimination of pathogenic V. anguillarum cells
[74,75]. And the putative engulfment of bacterial struc-
tures through the shedding of intestinal epithelial cells,
as an defence strategy in larval fish, were regularly visu-
alized in the gut lumen at the later stage of bacterial
challenge [74]. Hence, the observed antagonistic inter-
action of PirABVP toxin with Vibrio spp., might be
based on either toxin-induced enhanced immune
response or on shedding of epithelial cells eliminating
the pathogenic bacteria, resulting in decreased in vivo
virulence of V. campbellii LMG21363,
V. parahaemolyticus CAIM170, V. proteolyticus
LMG10942, and V. anguillarum NB10 strain (Figure
2(B–E)). Yet, such interaction did not happen with
all the studied Vibrio strains suggesting that the inter-
action is strain-dependent and might be influenced by
the virulence level of bacteria, the mechanistic of which
remains to be unravelled.
Moreover, a stochastic pattern of interaction was
observed in our in vitro experiment. The results
showed that addition of PirABVP toxin significantly
increase cell count and dead cell (%) in V. harveyi
MM30, V. alginolyticus AQ13-91, V. campbellii
LMG21363, and V. proteolyticus LMG10942, while
decreased value was recorded from V. harveyi
JMH603, V. parahaemolyticus CAIM170, and
V. anguillarum NB10 strain (Tables 3 and 5). Similar
to cell viability observations, the in vitro virulence
results showed that PirABVP toxin addition signifi-
cantly increases the swimming motility (V. harveyi
BB120, BB152, MM30, JMH603, and
V. parahaemolyticus CAIM170), caseinase activity
(V. harveyi BB120 and BB152) and lipase activity
(V. harveyi BB120 and JMH634). However, decreased
haemolysis activity in V. harveyi BB120 and
V. parahaemolyticus CAIM170, caseinase activity
V. harveyi MM30 and JMH603 were also recorded in
the presence of PirABVP toxin (Tables 4 and 6).
Though, these observations do not help to explain
the in vivo results, the preliminary observations suggest
that PirABVP toxin influences the cell viability and in
vitro virulence of the studied Vibrio spp.
In essence, the results presented here underscore
that presence of PirABVP toxin modulates the virulence
of Vibrio spp. in both in vivo and in vitro conditions.
Although, it remains to be established how PirABVP
toxin interacts with Vibrio spp., to the authors’
knowledge, these findings are the first of its kind, poss-
ibly pointing towards new insights in the infection pro-
cess of Vibrio spp. in presence of AHPND-causing
PirABVP. Since, in recent years the incidence of
AHPND mediated by PirABVP toxin has increased
enormously, further studies that focus on the inter-
action mechanism of PirABVP toxin and Vibrio spp.
in commercial shrimp species (e.g. Litopenaeus vanna-
mei, Penaeus monodon or Macrobrachium rosenbergii)
will help to better understand PirABVP toxins and
Vibrio spp. mediated infection process.
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